Poly-arginine and arginine-rich peptides are neuroprotective in stroke models BP Meloni, LM Brookes, VW Clark, JL Cross, AB Edwards, RS Anderton, ... Journal of Cerebral Blood Flow & Metabolism 35 (6), 993-1004, 2015 | 99 | 2015 |
Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties BP Meloni, D Milani, AB Edwards, RS Anderton, RLOH Doig, M Fitzgerald, ... Pharmacology & Therapeutics 153, 36-54, 2015 | 91 | 2015 |
Assessment of the neuroprotective effects of arginine-rich protamine peptides, poly-arginine peptides (R12-cyclic, R22) and arginine–tryptophan-containing peptides following in … BP Meloni, D Milani, JL Cross, VW Clark, AB Edwards, RS Anderton, ... Neuromolecular medicine 19, 271-285, 2017 | 41 | 2017 |
The Neuroprotective Peptide Poly- Arginine-12 (R12) Reduces Cell Surface Levels of NMDA NR2B Receptor Subunit in Cortical Neurons; Investigation into the Involvement of … G MacDougall, R Anderton, A Edwards, N Knuckey, B Meloni Journal of Molecular Neuroscience, 2016 | 41 | 2016 |
Perinatal hypoxic-ischemic encephalopathy and neuroprotective peptide therapies: A case for cationic arginine-rich peptides (CARPs) AB Edwards, RS Anderton, NW Knuckey, BP Meloni Brain sciences 8 (8), 147, 2018 | 35 | 2018 |
Modification to the Rice-Vannucci perinatal hypoxic-ischaemic encephalopathy model in the P7 rat improves the reliability of cerebral infarct development after 48 hours AB Edwards, KW Feindel, JL Cross, RS Anderton, VW Clark, NW Knuckey, ... Journal of neuroscience methods 288, 62-71, 2017 | 34 | 2017 |
Assessment of R18, COG1410, and APP96-110 in excitotoxicity and traumatic brain injury LS Chiu, RS Anderton, JL Cross, VW Clark, AB Edwards, NW Knuckey, ... Translational Neuroscience 8 (1), 147-157, 2017 | 32 | 2017 |
Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat AB Edwards, JL Cross, RS Anderton, NW Knuckey, BP Meloni Molecular Brain 11, 1-12, 2018 | 27 | 2018 |
Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model A Edwards, R Anderton, N Knuckey, B Meloni Molecular and Cellular Biochemistry, 2016 | 24 | 2016 |
Neuroprotective cationic arginine-rich peptides (CARPs): An assessment of their clinical safety A Edwards, F Mastaglia, N Knuckey, B Meloni Drug Safety, 2020 | 16 | 2020 |
Assessment of therapeutic window for poly‐arginine‐18D (R18D) in a P7 rat model of perinatal hypoxic‐ischaemic encephalopathy AB Edwards, RS Anderton, NW Knuckey, BP Meloni Journal of Neuroscience Research 96 (11), 1816-1826, 2018 | 10 | 2018 |
Impact of poly-arginine peptides R18D and R18 on alteplase and tenecteplase thrombolysis in vitro, and neuroprotective stability to proteolysis BP Meloni, DJ Blacker, AB Edwards, NW Knuckey Journal of Thrombosis and Thrombolysis 54 (1), 172-182, 2022 | 6 | 2022 |
Assessment of R18, COG1410, and APP96-110 in excitotoxicity and traumatic brain injury. Transl Neurosci 8: 147–157 LS Chiu, RS Anderton, JL Cross | 4 | 2017 |
Assessment of the safety of the cationic arginine-rich peptides (CARPs) poly-arginine-18 (R18 and R18D) in ex vivo models of mast cell degranulation and red blood cell hemolysis AB Edwards, FL Mastaglia, NW Knuckey, KH Yip, B Meloni Biochemistry and Biophysics Reports 31, 101305, 2022 | 3 | 2022 |
Comparative assessment of the proteolytic stability and impact of poly-arginine peptides R18 and R18D on infarct growth and penumbral tissue preservation following middle … D Milani, VW Clark, KW Feindel, DJ Blacker, M Bynevelt, AB Edwards, ... Neurochemical Research 46, 1166-1176, 2021 | 3 | 2021 |
Neuroprotective efficacy of poly-arginine-18 (R18) peptides using an in vivo model of perinatal hypoxic ischaemic encephalopathy A Edwards, K Feindell, J Cross, R Anderton, V Clark, N Knuckey, B Meloni Journal of Cerebral Blood Flow and Metabolism 37, 18-19, 2017 | 3 | 2017 |
Adult polyglucosan body disease: an acute presentation leading to unmasking of this rare disorder J Johal, R Castro Apolo, MW Johnson, MR Persch, A Edwards, P Varade, ... Hospital Practice 50 (3), 244-250, 2022 | 2 | 2022 |
Improving clinical outcomes in a neurocritical intensive care unit through collaboration and innovation S Varade, K Sivakumar, A Edwards, P Varade METHODS 59, 51.75, 2017 | 1 | 2017 |
Hemi-Orolingual Angioedema After Tissue Plasminogen Activator (tPA) Administration in Acute Ischemic Stroke S Shaikh, A Lacasse, N Singh, A Edwards, V Kumar TP7. TP007 PULMONARY AND ALLERGY CASE REPORTS, A1374-A1374, 2021 | | 2021 |
Eclampsia Resulting in Posterior Reversible Encephalopathy Syndrome with Spinal Cord and Optic Nerve Involvement (4971) N Moheb, E Rehim, C Judge, RC Apolo, A Edwards Neurology 96 (15_supplement), 4971, 2021 | | 2021 |